KEYLAB Trademark

Trademark Overview


On Friday, May 19, 2023, a trademark application was filed for KEYLAB with the United States Patent and Trademark Office. The USPTO has given the KEYLAB trademark a serial number of 98005200. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 14, 2024. This trademark is owned by Keylab Medical Co., Ltd.. The KEYLAB trademark is filed in the Pharmaceutical Products category with the following description:

Antiseptics; Disinfectants for hygiene purposes; Diagnostic preparations for medical or veterinary purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Disinfectants; Blood for medical purposes; Germicides; Reagents for use in medical genetic testing; Medical diagnostic reagents; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation
keylab

General Information


Serial Number98005200
Word MarkKEYLAB
Filing DateFriday, May 19, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Goods and ServicesAntiseptics; Disinfectants for hygiene purposes; Diagnostic preparations for medical or veterinary purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Disinfectants; Blood for medical purposes; Germicides; Reagents for use in medical genetic testing; Medical diagnostic reagents; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKeylab Medical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoshan 528000
CN

Party NameKeylab Medical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJun'an, Shunde, Foshan 528000
CN

Trademark Events


Event DateEvent Description
Tuesday, May 23, 2023NEW APPLICATION ENTERED
Thursday, June 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 13, 2024ASSIGNED TO EXAMINER
Wednesday, February 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 4, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, November 7, 2024TEAS STATEMENT OF USE RECEIVED